Skip to content

Eqwal Meise: what changed

BE 0449.997.450NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€819,041
2024 · €934,496-€115,455
Equity
€1.9m
2024 · €1.1m+€819,042
Cash
€207
2024 · €2,838-€2,631
Balance sheet total
€3.4m
2024 · €2.7m+€729,952

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€738,052

    up €738,052 (+28.8%), from €2.6m to €3.3m

    of which Other amounts receivable: +€671,550

Equity and liabilities
  • Profit (loss) carried forward +€819,042

    up €819,042 (+76.3%), from €1.1m to €1.9m

  • Tax, wage and social debts -€224,783

    down €224,783 (-42.2%), from €532,358 to €307,575

    of which Taxes: -€248,809

  • Trade debts +€135,692

    up €135,692 (+108%), from €125,250 to €260,942

Income statement
  • Financial income -€90,765

    down €90,765 (-76.9%), from €117,987 to €27,222

  • Staff costs +€76,237

    up €76,237 (+11.7%), from €651,445 to €727,682

  • Taxes -€40,547

    down €40,547 (-12.1%), from €333,893 to €293,346

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €934,496
Gross operating margin +€15,225
Staff costs -€76,237
Depreciation -€1,680
Other operating charges -€3,502
Financial income -€90,765
Financial charges +€958
Taxes +€40,547
Result 2025 €819,041
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€8,082
Investment -€10,714
Financing +€1
Cash 2024 €2,838
Net result for the year +€819,041
Depreciation +€9,628
Stocks and contracts +€575
Receivables within one year -€738,052
Deferred charges and accrued income +€5,979
Trade debts +€135,692
Tax, wage and social debts -€224,783
Investment in fixed assets (net) -€10,714
Contributions, distributions and other +€1
Cash 2025 €207
brings cash intakes cash out
Every line side by side 40 lines
Line Code 2024 2025 Change %
Total assets 20/58 €2,650,015 €3,379,967 +€729,952 +27.5%
Fixed assets 21/28 €25,777 €26,862 +€1,085 +4.2%
Tangible fixed assets 22/27 €25,777 €26,862 +€1,085 +4.2%
Plant, machinery and equipment 23 €16,046 €13,245 -€2,802 -17.5%
Other tangible fixed assets 26 €9,730 €13,617 +€3,887 +40.0%
Current assets 29/58 €2,624,239 €3,353,105 +€728,866 +27.8%
Stocks and contracts in progress 3 €47,439 €46,864 -€575 -1.2%
Stocks 30/36 €47,439 €46,864 -€575 -1.2%
Amounts receivable within one year 40/41 €2,559,714 €3,297,765 +€738,052 +28.8%
Trade receivables 40 €1,054,044 €1,120,545 +€66,502 +6.3%
Other amounts receivable 41 €1,505,670 €2,177,220 +€671,550 +44.6%
Cash at bank and in hand 54/58 €2,838 €207 -€2,631 -92.7%
Deferred charges and accrued income 490/1 €14,248 €8,269 -€5,979 -42.0%
Total equity and liabilities 10/49 €2,650,015 €3,379,967 +€729,952 +27.5%
Equity 10/15 €1,092,408 €1,911,450 +€819,042 +75.0%
Contributions 10/11 €18,550 €18,550 = 0.0%
Reserves 13 €992 €992 = 0.0%
Distributable reserves 133 €992 €992 = 0.0%
Profit (loss) carried forward 14 €1,072,866 €1,891,908 +€819,042 +76.3%
Amounts payable 17/49 €1,557,607 €1,468,517 -€89,091 -5.7%
Amounts payable within one year 42/48 €1,557,607 €1,468,517 -€89,091 -5.7%
Trade debts 44 €125,250 €260,942 +€135,692 +108%
Suppliers 440/4 €125,250 €260,942 +€135,692 +108%
Taxes, remuneration and social security 45 €532,358 €307,575 -€224,783 -42.2%
Taxes 450/3 €407,122 €158,312 -€248,809 -61.1%
Remuneration and social security 454/9 €125,236 €149,263 +€24,027 +19.2%
Other amounts payable 47/48 €900,000 €900,000 = 0.0%
Remuneration, social security and pensions 62 €651,445 €727,682 +€76,237 +11.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €7,948 €9,628 +€1,680 +21.1%
Other operating charges 640/8 €3,218 €6,720 +€3,502 +109%
Gross operating margin 9900 €1,815,180 €1,830,405 +€15,225 +0.8%
Operating profit (loss) 9901 €1,152,570 €1,086,375 -€66,195 -5.7%
Financial income 75/76B €117,987 €27,222 -€90,765 -76.9%
Recurring financial income 75 €117,987 €27,222 -€90,765 -76.9%
Financial charges 65/66B €2,168 €1,211 -€958 -44.2%
Recurring financial charges 65 €2,168 €1,211 -€958 -44.2%
Profit (loss) for the period before taxes 9903 €1,268,389 €1,112,387 -€156,002 -12.3%
Income taxes 67/77 €333,893 €293,346 -€40,547 -12.1%
Profit (loss) for the period 9904 €934,496 €819,041 -€115,455 -12.4%
Profit (loss) for the period to be appropriated 9905 €934,496 €819,041 -€115,455 -12.4%

Value

latest balance sheet 30-09-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€4.1m to €5.3m

Midpoint €4.6m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €1.9m
Capitalised earnings €6.2m to €8.7m
Indication €4.1m to €5.3m

Adjusted equity

balance sheet 30-09-2025
Equity (10/15)
€1,911,450
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€1.9m

Capitalised earnings

net result for the year (9904)
2025
€819,041
2024
€934,496
2023
€869,636
2022
€800,014
2021
€861,564
Average result
€874,391
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€6.2m / €7.3m / €8.7m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 September 2024 and 30 September 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.